发明名称 IMPROVEMENT IN THERAPY OF INFECUNDITY
摘要 PURPOSE: To inspect effect of medical care with combination of GH/gonadotropic hormone by giving a specified amount of clonidine or clonidine derivative to a patient, and monitoring in-blood concentration of human growth hormone(HG) after administration. CONSTITUTION: Clonidine hydrochloride salt of about 0.25-0.6mg is given in oral administration. A patient of chronisin-negative is further administered with combination of GH/gonadotropic hormone. At that time, in order to induce GH-freeing from a pituitary, about 1μg/kg of GH, as it is, or growth hormone free hormone(GHRH) alone, is administered. In case of latter, if in-blood concentration of GH does not rise much, a pituitary is loosing GH, so, only GH/ gonadotropic hormone remedy is effective. If there is positive response to GHRH, a hypothalamus is loosing GH, and for such patient, both GHRH and GH/gonadotropic hormone are effective. This test can be performed rapidly, and medical care for sterility can be started reasonably and instantly along with high possibility in success.
申请公布号 JPH03218467(A) 申请公布日期 1991.09.26
申请号 JP19900264909 申请日期 1990.10.02
申请人 APPLIED RESEARCH SYSTEMS 发明人 LUNGENFELD BRUNO;MENASHE YEHESKEL
分类号 G01N33/50;A61B10/00;G01N33/74;G01N33/76 主分类号 G01N33/50
代理机构 代理人
主权项
地址